Fosun Pharmaceu...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Concert Pharmaceuticals
Fosun Pharmaceutical bought Concert Pharmaceuticals
1/19/23 at 17:11
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.
Concert Pharmaceuticals
Review
Source:
ir.concertpharma.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Lambumiz reported for 2024 by IFRS
4/30/25
LMBZ
Board of Directors of Acron recommended that dividends be paid for 2024
4/30/25
AKRN
Board of Directors of Acron recommended that dividends be paid for 2024
4/30/25
AKRN
UTair Aviation reported for 3 months of 2025 by RAS
4/30/25
UTAR
KuibyshevAzot reported for 3 months of 2025 by RAS
4/30/25
KAZT
Magnit buys a controlling stake in Azbuka Vkusa
4/30/25
MGNT
Sovcombank reported for 2024 by RAS
4/29/25
SVCB
MMK-METIZ reported for 2024 by IFRS
4/29/25
MMMZ
PIK reported for 3 months of 2025 by RAS
4/29/25
PIKK
APRI reported for 2024 by IFRS
4/29/25
APRI
«
Previous
19
20
21
22
23
24
25
26
27
28
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
ir.concertpharma.com ir.concertpharma.com ir.concertpharma.com
English (US) 